Thousands of oncology experts from around the world will tune in May 29-31 for the American Society of Clinical Oncology’s (ASCO) Virtual Scientific Program. The online meeting will provide an engaging lineup of scheduled and on-demand scientific content including a plenary session, oral, poster and poster discussion sessions, and a track-based Clinical Science Symposia.
Connecting virtually around this year’s theme “Unite & Conquer: Accelerating Progress Together,” the brightest minds in oncology will be presenting state-of-the-art treatment modalities and new therapies. Memorial Sloan Kettering (MSK) physicians and scientists are involved in notable research to be presented at the meeting and are available to comment on topics such as clinical trials, immunotherapy, cancer prevention, risk reduction, genetics, health services research and quality improvement, care delivery and regulatory policy, and much more.
MSK experts Anna Lee, MD, MPH, and Fumiko Chino, MD, were featured in the meeting’s press program on May 13, highlighting their landmark research on the impact of Medicaid expansion on cancer mortality rates. We are also proud to announce that three MSK doctors, Heather Hylton, MS, FASCO, Stuart Lichtman, MD, FACP, FASCO, and Mark Robson, MD, FASCO are being honored by the Fellow of the American Society of Clinical Oncology (FASCO) this year.
For more information and to set up interviews, contact firstname.lastname@example.org or email@example.com. Registration is required for all attendees: https://meetings.asco.org/am/registration. Follow the meeting live on Twitter using the hashtag #ASCO20 and follow MSK on Twitter at @sloan_kettering.